Home › Multiple Sclerosis › Kansas
Multiple Sclerosis clinical trials in Kansas
9 studies for Multiple Sclerosis are looking for participants at sites in Kansas.
Cities in Kansas
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Roeland Park
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06433752Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- and 7 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- University of Kansas Medical Center, Kansas City
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT07477639RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- The University of Kansas Medical Center, Kansas City
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- University of Kansas Medical Center, Kansas City
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 9, 2026 · NCT06782490A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- University of Kansas Hospital, Kansas City
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 29, 2026 · NCT07225504Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis
- University of Kansas Medical Center, Kansas City
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Jun 12, 2026 · NCT06428006Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection
- University of Kansas Medical Center- Sleep, Health and Wellness Laboratory, Kansas City
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Oct 9, 2025 · NCT06434571Dry Needling in Multiple Sclerosis
- Mobility and Falls Lab, Kansas City
Recruiting
Ages 18 to 64 · All sexes · Updated Jun 11, 2025 · NCT06394310From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.